Aptorum Group LTD Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Kira S. Sheinerman has filed a Schedule 13D, reporting beneficial ownership of 1,515,293 shares, or 51.56%, of Niki BioSolutions, Inc. common stock, acquired as merger consideration.